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Abstract 
The current paper provides a review of the current knowledge on the health benefits of 
probiotics and the effect they may have on mood disorders.  It also highlights the role of 
exercise as an alternative therapy for combating mood disorders.  Depression is a substantial 
contributor to the global disease burden and therefore any alternative therapy must be 
considered.  Probiotics influence the gut microbiota through a complex network of events 
which can influence mechanisms leading to development of mood disorders such as 
depression and anxiety.  Similarly, through a complex interaction between psychological and 
neurobiological mechanisms, exercise has been found to play a key role in mood 
enhancement.    
Keywords Probiotics, gut microbiota, chronic disease, exercise, obesity 
Background 
At birth, the sterile human gut is immediately colonised with several types of microorganisms 
from both the mother and the environment. This results in each individual developing a 
unique bacterial profile by the time they reach 12 months in age, forming the basis of their 
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adult gastrointestinal (GI) tract (Forsythe et al., 2010). The distinct microbiome of each 
individual is determined through interactions between sex, diet, immune status, infection, GI 
disorders, antibiotics and drugs with the adult human GI tract comprised of at least 160 
different bacterial species from a pool 1000-1150 (Marik, 2012). Within the pool there are 
neutral and pathogenic bacteria species alongside probiotic bacteria which prevail in a 
healthy gut (Desbonnet et al., 2004; Messaoudi et al., 2011).   
Probiotic – ‘supporting or favouring life’ (Lilly and Stillwell, 1965) 
Probiotic bacteria are live microorganisms known as ‘friendly’ gut bacteria which when 
present and/or administered in adequate amounts can have potential health benefits to the 
host organism (WHO, 2001; van Baarlen et al., 2011; Bravo et al., 2012; Pyne et al., 2015).  
The health benefits of ‘probiotic bacteria’ have been recognised for several hundred years 
(Jankovic et al., 2010), with the earliest record from 76 BC where Roman historian Plinio 
described how fermented milk could be used as a therapy for GI disturbances (Bottazzi, 
1983).  However it wasn’t until the invention of the microscope that micro-organisms and 
bacteria were discovered.  At the turn of the 20th century, Elie Metchnikoff suggested that 
fermented milk could suppress the growth of proteolytic bacteria and in turn reduce 
putrefaction in the gut and so prolong the lifespan of the host (Metchnikoff, 1907).  
Following this discovery, lactic acid bacteria and other bacteria began to be added to drugs 
used to treat diarrhoea and to food products to promote intestinal health and disease 
prevention (Jankovic et al., 2010). 
Within contemporary society, probiotic bacteria are widely used for health promotion and 
health improvement (Ohashi and Ushida, 2009).  Probiotic bacteria occur naturally within 
fermented food products such as yoghurt, sauerkraut, cabbage kimchee and soy bean based 
miso and natto (Nichols, 2007).  However, food supplements generally in the form of 
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cultured dairy products are now widely available to consumers which have added probiotic 
bacteria. More recently ‘probiotic shots’ have been developed where probiotics can be 
consumed as a capsule.  Contained within these food supplements there can be many strains 
of bacteria; however, the most common strains belong to the species Lactobacilli and 
Bifidobacteria (Benton et al., 2007), both of which are recognised for their health benefits on 
the human body. For example, both these strains of bacteria are known to be involved in 
essential physiological functions such as the stimulation of immune response, the prevention 
of pathogenic bacteria formation, the production of short chain fatty acids, metabolism of 
cancerogenic substances and the synthesis of vitamins such as B and K (Logan et al. , 2003). 
For bacteria to be classed as a probiotic, there are five essential criteria which have to be 
fulfilled.  The current essential criteria are outlined by West et al., (2009) as: 
1. Viability during processing, transport and storage. 
2. Ability to survive gastric transport. 
3. Ability to adhere to and colonise the GI tract. 
4. Ability to antagonise pathogenic bacteria. 
5. Demonstration of clinical health outcomes 
It is, however, important to realise that these criteria are continually evolving, largely due to 
the increasing research within the field. 
Health Benefits Of Probiotics 
Overview 
The proposed health benefits of probiotics are widespread.  For example, West et al., (2014) 
found that probiotics could be used to reduce the risk of developing upper respiratory tract 
infections (URTI) in healthy young adults.  However, the focus of the present paper will be 
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on the influence of probiotics on chronic inflammatory disease, chronic medical conditions 
and mood disorders. This is pertinent as there is substantial evidence supporting the co-
morbidity of mood disorders and chronic medical conditions (Forsythe et al., 2010).  This is 
evident in individuals with depression who also have high rates of obesity, hypertension, 
dyslipidaemia, metabolic syndrome and diabetes (Basu et al., 2004; Heiskanen et al., 2006). 
All the afore mentioned conditions are also linked to a lack of physical activity, which is 
again associated with the development of mood disorders (Stohle, 2009). 
In 2015, the World Health Organisation estimated that globally 350 million people suffer 
from depression making it the leading cause of disability worldwide and so a substantial 
contributor to the global health burden (WHO, 2015). Furthermore, 63% (36 million) of all 
deaths worldwide in 2008 were due to non-communicable diseases, primarily, cardiovascular 
disease, diabetes, cancer and chronic respiratory disease (Alwan et al. , 2010). With the 
prevalence of chronic medical conditions and mood disorders continually rising, it is essential 
that any potential adjunctive therapy, such as the use of probiotics and/or exercise 
prescription must be seriously considered.   
Irritable Bowel Syndrome (IBS) 
Approximately 30% of individuals with major depressive disorder have diagnosable IBS 
which is known to cause a reduction in intestinal Lactobacilli and Bifidobacteria (Logan and 
Katzman, 2005). It has been hypothesised that one factor leading to the rise of IBS in modern 
society is due to the decreased exposure to mud, animals and faeces, also known as the ‘old 
friends hypothesis’.  This has consequently led to a decrease in contact with microorganisms 
which play a vital role in developing immunoregulatory responses in humans (Rook et al. , 
2012).  This is also known as the ‘hygiene hypothesis’ whereby the rise in chronic 
inflammatory disease such as IBS is hypothesised to be partly due to changes in the microbial 
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environment in developed countries i.e. the absence of ‘good’ bacteria which are normally 
able to supress the inflammatory response.  Increased levels of inflammatory cytokines are 
common in various mental health conditions and can produce symptoms of anxiety and 
depression (Rao et al., 2009) with some risk factors including obesity, psychosocial stress, 
social isolation, sedentary lifestyle (Rook et al., 2012). Therefore, if probiotics are able to 
decrease inflammatory cytokines and so IBS symptoms in humans, it can be hypothesised 
that they could have a positive effect on mood (Logan et al., 2005). 
Chronic Fatigue Syndrome  
Chronic fatigue syndrome is a complex illness which is poorly understood.  In addition to 
periods of persistent fatigue, approximately 50% of sufferers are affected by anxiety or major 
depressive disorder (Rao et al., 2009).  Furthermore, many chronic fatigue syndrome patients 
have complaints of GI disturbances with over 50% diagnosed with IBS (Whitehead et al., 
2002) and subsequently reduced levels of Bifidobacteria alongside elevated levels of aerobic 
bacteria such as enterococci (Logan et al., 2003). Therefore, if probiotics have a positive 
effect on mood disorders and IBS, there is the potential for them to be beneficial to sufferers 
of chronic fatigue syndrome. 
Common Symptoms 
Individuals who are affected by these various medical disorders like IBS, chronic fatigue 
syndrome and others such as fibromyalgia (a chronic disorder characterized by widespread 
musculoskeletal pain) and endometriosis (a disease in which tissue that normally grows 
inside the uterus grows outside it with symptoms of pelvic pain and infertility) are affected by 
a number of common symptoms including pain, fatigue, sleep, memory and mood issues.  In 
particular individuals suffering from these disorders frequently have a migration of bacteria 
from the colon to the small intestine causing a small intestinal bacterial overgrowth which is 
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associated with greater levels of somatic pain (Pimental et al., 2004).  Pain and discomfort is 
regularly associated with symptoms of depression. Although small intestinal bacterial 
overgrowth has not been investigated in those with major depressive disorder, Logan and 
Katzman (2005) have hypothesised that it is likely to occur in these individuals due to low 
levels of stomach acid which can lead to small intestinal bacterial overgrowth. In this 
situation probiotics are a potential treatment, which may have a consequential positive effect 
on mood (Gaon et al., 2002).   
Probiotics And The Microbiota 
The various inflammatory and metabolic disorders described above may be a result of 
dysbiosis i.e. disruption in the interactions between microbes and the host (Hermarajata and 
Versalovic, 2012).  Probiotics may be able to partially restore the host’s microbiota through 
various mechanisms.  Bravo et al., (2012) have provided an overview of the mechanisms by 
which probiotics are thought to work.  The network of events outlined include: 
 Displacement of pathogens  
 Competition of metabolic interactions with hostile bacteria 
 Production of bacteriocins (proteinaceous toxins produced by bacteria to inhibit the 
growth of similar or closely related bacterial strains) 
 Inhibition of bacterial translocation 
 Enhancement of mucosal barrier function 
 Effects on calcium dependant potassium channels in intestinal sensory neurons 
 Induction of opioid and cannabinoid receptors in intestinal epithelial cells 
 Modulation of the immune system through signals on epithelial cells and gut-
associated lymphoid tissue 
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Probiotic bacteria are able to displace pathogens through the production of antimicrobial 
agents which supress the growth of other microorganisms (O’Shea et al., 2011) or through 
competing with other microbes on the intestinal mucosa for binding sites and receptors 
(Collado et al., 2007).  Enhancement of mucosal barrier function may result in improved 
immune function; for example, Lactobacillus has been found to improve barrier function due 
to decreased translocation of bacteria across the mucosa and disease phenotypes such as IBS 
(Lee and Bak, 2011). However, further studies on humans are needed to enhance our 
understanding of the processes involved in disease phenotypes such as IBS. 
Mechanisms By Which Probiotics May Influence Mood  
Probiotic bacteria work through a very complex network of events, with compelling evidence 
to suggest that there is involvement of both anatomical connections such as the vagus nerve 
and humoral components such as the immune system and hypothalamus-pituitary-adrenal 
(HPA) axis (Bravo et al., 2012).   
When activated the HPA axis releases corticotrophin-releasing factor from the hypothalamus, 
adrenocorticotrophic hormone (ACTH) from the pituitary and cortisol from the adrenal 
glands (Cryan and Dinan, 2012). Evident suggests a contributing factor linked to both 
depression and stress is an impaired HPA system (Belmaker and Agam, 2008). When the role 
of the HPA axis in stress was investigated in mice by Sudo et al., (2004) who found that 
restraint stress in germ-free mice caused an inflated rise in ACTH and corticosterone; 
however, this response was able to reversed by Bifidobacteria infantis.    
The vagus nerve plays a key role in modulation and communication between bacteria, gut 
and brain, also known as the microbiota-gut-brain axis (Desbonnet et al., 2009). This axis 
allows bidirectional communication whereby the brain can functionally affect the gut and the 
gut can mediate changes in the central nervous system (CNS) (Mayer et al., 2006).  Any 
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dysfunction or alteration of the axis can have pathophysiological effects (Cryan and Dina, 
2012) which may be involved in modulating various factors including pain perception, 
emotion and general well-being (Rhee et al., 2009). Gamma-aminobutyric acid (GABA) is 
the main inhibitory neurotransmitter in the CNS and is involved in regulating many 
physiological and psychological processes where any alterations in GABA receptor 
expression can result in symptoms of depression or anxiety (Bravo et al., 2012).  
The importance of the vagus nerve in communicating changes in the GI to the CNS has been 
shown in rodents whose vagus nerve was cut.  A strain of probiotic, L. rhamnosus (JB.1), was 
found to reduce stress-induced elevation in corticosterone; however, these effects were not 
evident in the vagotomised mice (Bravo et al., 2012). This provides further evidence to 
support the use probiotics as a therapeutic alternative to reduce mood disorders such as stress, 
anxiety and depression.  It is important to note that this is a brief overview of the mechanisms 
involved; however, within the literature the various mechanisms and pathways are discussed 
in greater detail e.g. Bravo et al., (2012). 
The Effect Of Probiotics On Mood Disorders  
In recent years there has been a substantial increase in the number of studies investigating the 
effects of probiotics on various mood disorders. However, the idea that probiotics may 
improve certain mental health disorders is not a novel concept but rather one which has been 
recognised for several decades.  For example, in 1910 it was reported that live lactic acid 
bacteria improved symptoms of depression in adults with melancholia (Philips, 1910).  A 
selection of more recent work relating to probiotics and mood disorders are outlined below.  
The reader should be aware that a number of the more invasive studies have, to date, only 
been carried on in animals, therefore the applicability to humans needs to be taken into 
consideration. 
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Human Studies 
As outlined previously, there is an established link between chronic constipation and mood 
scores, therefore, Benton et al., (2001) investigated the impact of consuming a probiotic on 
mood and cognition. Results suggested that more frequent constipation was associated with a 
poorer mood state, in addition to, an inverse association between constipation and feelings of 
calmness, elatedness and agreeableness.  However, the correlational nature of data prevented 
the conclusion of a causal relationship between constipation and mood state. Due to the 
continual speculation that probiotics may be a valuable adjuvant therapy for those with major 
depressive disorder  in a more recent study, the same group of authors (Benton et al., 2007) 
investigated the effect of a fermented milk drink containing Lactobacillus casei probiotic 
bacteria (Yakult) on mood and cognition.  Again it was suggested that reduced constipation 
may play a role in improving mood disorders.  However, daily ingestion of the probiotic, for 
a period of three weeks, failed to show any improvement in mood or an increase in the 
number of motions passed.  The authors suggested that the lack of improvements may be 
related to the participants having a ‘good’ baseline mood with low levels of constipation.   
There are however, a number of studies which have found a significant improvement in mood 
disorders with the consumptions of probiotics.  A six month study investigating the effects of 
a probiotic multivitamin compound on adults suffering from stress or exhaustion was 
conducted by Gruennwald et al., (2002).  The overall conclusion to emerge from the study 
was that the multivitamin compound significantly improved the general condition of those 
who participated in the study.  The authors found a 41% improvement in stress alongside a 
decrease of 29% in the prevalence of infection and 91% reduction in GI discomfort, both of 
which are indicators of stress. An intervention study investigating the effects of a lactic acid 
probiotic in patients with chronic fatigue syndrome and associated depression and anxiety 
was carried out by Rao and colleagues (2009).  The intervention group consumed a probiotic 
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containing a strain of Lactobacillus three times per day.  Following an eight week trial, 
compared to the placebo group, the treatment group were found to have a significant 
improvement in anxiety scores alongside an increase in faecal Bifidobacteria and 
Lactobacillus (73.7% and 73.7%), the changes in depression scores were not found to be 
significant.  
Recently, Steenbergen et al., (2015) investigated the effect of a multispecies probiotic on 
cognitive reactivity to sad mood.  The participants in this study were not diagnosed with 
having a mood disorder, however, compared to the control group it was found that those who 
consumed the probiotic over a four week period significantly reduced their cognitive 
reactivity to sad mood.  This is important due to the risk of sad mood developing into clinical 
depression. 
Although, there are limited human studies which have investigated the use of probiotics in 
the treatment of mood disorders, the current evidence suggests that it would be naïve to rule 
out the use of probiotics as an adjunctive therapy (Foster and McVey Nuefeld, 2013). 
Animal Studies 
The psychotropic properties of a probiotic formulation has been assessed in both rats and 
humans by Messaoudi et al., (2011).  The main finding to emerge from this study was that 
consumption of the probiotic formula containing a combination of L. helveticus R0052 and B. 
Longum R0175 mitigated psychological distress in three tests without displaying any adverse 
events.  In humans, the formula was taken for 30 days and resulted in significant 
improvements on scales used to measure depression, anxiety and hostility.  Within the paper 
it is suggested that the effects of probiotics on anxiety and depression may be due to 
competitive exclusion of detrimental gut pathogens, decreases in pro-inflammatory cytokines 
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and communication with the CNS via vagal sensory fibres, leading to changes in 
neurotransmitter levels or function.   
The potential antidepressant properties of Bifidobacteria infantis in the rat were investigated 
by Desbonnet and colleagues (2009) and it was found that chronic administration of the 
probiotic protected the rats from depressive symptoms caused by stress induced through 
maternal separation.  The results of this study suggested that probiotics may be a suitable 
alternative to tryptophan supplement as a therapy for depression, although the authors 
highlight that these findings are preliminary and further investigation would be required to 
establish precise mechanisms. 
Alternatively, administering a pathogenic bacteria to healthy mice has been shown to 
stimulate anxiety behaviours within hours of infection suggesting that changes in the gut 
microbiota can very quickly induce biochemical changes in the CNS (Lyte et al., 2006; 
Goehler et al., 2008).  This highlights that altering the gut microbiota can have an effect on 
animal behaviour and so providing further evidence for the existence of the microbiota-gut-
brain-axis (Bravo et al., 2012). 
Although not conclusive, both animal and human studies, present a significant claim for the 
use of probiotics as an alternative treatment, particularly in those individuals with pre-
existing mood disorders. 
The Effect Of Exercise On Mood Disorders And Chronic Medical Conditions  
There is a well-established link between physical inactivity and the risk of various non-
communicable diseases which coincides with an increased prevalence of mood disorders.  
Both epidemiological and clinical studies have shown there to be a correlation between 
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physical activity levels and prevalence of mood disorders, with physical activity generally 
having a positive effect on mood (Ströhle, 2009).   
There are several studies where this link between physical activity and depression is evident; 
for example, a longitudinal study by Paffenbarger et al., (1994) found physical activity levels 
in men to be negatively correlated with depression 25 years later.  This is similar to the 
findings of Motl et al., (2004) who found natural changing levels of physical activity in 
adolescents was inversely related to depressive symptoms. 
Over the last 10-15 years there has been an increase in the number of controlled trials 
investigating the effects of prescribed exercise as a therapy for depression and other mood 
disorders.  Dunn et al., (2005) investigated the effects of various aerobic exercise protocols 
on mild to moderate major depressive disorder in 20-45 year olds.  The authors were able to 
conclude that exercise  prescribed in a dosage aligned with public health recommendations 
was an effective treatment for mild to moderate symptoms of major depressive disorder and 
that greater energy expenditure is associated with larger decreases in symptoms of 
depression.  Furthermore Blumenthal et al., (1999) was able to conclude that an exercise 
training programme for older adults with major depression was as effective as administering 
an antidepressant treatment and had a lower relapse rates. 
Additional support for the role of exercise in mood enhancement comes from a study where 
participants attended a regular exercise class for three months.  It was found that 
improvements in mood were significantly greater in those individuals who had reported 
symptoms of depression prior to beginning the exercise programme (Lane and Lovejoy, 
2001). 
Although there is a well-established association between exercise and mood enhancement, 
the physiological mechanisms underlying the relationship between mood and exercise are 
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poorly understood. However, it is likely that the mechanisms for exercise induced 
improvements in mood disorders is a complex interaction between psychological and 
neurobiological mechanisms (Strohle, 2009).  Typically, exercise decreases inflammation 
which in turn reduces the activity and expression of the enzyme indoleamine 2,3-
dioxygenase, which degrades tryptophan (an essential amino acid needed for the production 
of serotonin) (Gostner et al., 2015).  This therefore allows for an increase in tryptophan which 
when transported to the brain can increase the production of 5-hydroxytryptomin which can 
subsequently lead to an increase in mood state (Strasser et al., 2015). 
In an attempt to gain a greater understanding of the relationship between mood and exercise, 
Poole et al., (2011) investigated the effects of exercise withdrawal on mood and 
inflammatory cytokine response.  Two weeks of exercise withdrawal in healthy participants 
resulted in significant increases in negative mood which was significantly related to a 
decrease in circulating interleukin (IL)-6 (inflammatory marker), indicating that 
inflammatory pathways do play a role in the development of mood disorders. 
Even if exercise was found not to enhance mood, it should always be recommended whether 
to combat the various chronic medical conditions previously mentioned or simply to maintain 
a healthy lifestyle and prevent disease. 
Gut Microbiota, Obesity And Diet 
There is considerable evidence which has emerged from obesity studies highlighting the link 
between diet, obesity and a ‘healthy gut microbiota’.  Obesity is a worldwide epidemic in 
both adults and children and is a major health concern within society.  It can be largely 
attributed to an unhealthy lifestyle consisting of an abundance of energy dense food and 
physical inactivity; however, there is now compelling evidence suggesting that there are 
differences in the gut microbiota of obese and lean individuals.  This brings to light the 
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possibility that the development of obesity and other metabolic diseases may be influenced in 
some way by the gut microbiota (Marik, 2012; Serino et al., 2012). It also is interesting to 
note that there has been a correlation found between diet and the prevalence of specific 
bacteria groups; for example, a diet high in inulin and related fibres has been shown to 
increase Bifidobacteria (Marik, 2012). This suggests that diet can change both the 
composition and activity of the microbiota and thereby possibly having a positive impact on 
mood disorders.  
Backhed et al., (2004) investigated the role of the gut microbiota in the regulation of fat 
storage in mice.  The authors found the germ-free mice had 40% less body fat compared to 
conventionally reared mice; this was despite the germ-free mice consuming more food.  
However, when the microbiota was harvested from the distal intestine of the normal mice and 
transplanted into the germ-free mice, this resulted in a 60% increase in body fat content 
within two weeks.  From the results, it was proposed that the microbiota promotes 
monosaccharide absorption resulting in de novo hepatic lipogenesis (conversion of surplus 
energy to fat in the liver).  It was concluded that the gut microbiota is an important 
environmental factor which can affect energy storage of the host organism. 
The role of the gut microbiota in the development of obesity in humans has been 
demonstrated by Kalliomaki et al., (2008).  Investigation of the faecal matter of children 
revealed that Bifidobacteria content was higher in children of a normal weight than those 
who were showing signs of becoming overweight.  This gives rise to the possibility that 
consumption Bifidobacteria to manipulate the gut microbiota may have a positive effect on 
weight control in humans. 
On consideration of the preceding evidence it can be suggested that the gut microbiota may 
influence metabolism, consequently impacting energy storage which may be linked to the 
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development of chronic medical conditions such as type II diabetes and obesity, where there 
is significant evidence for co-morbidity with mood disorders (Turnbaugh et al., 2006). 
Conclusion. 
In summary, it seems reasonable to advocate the use of probiotics as an alternative therapy in 
the treatment of neuropathological disorders as an alternative or in addition to traditional 
therapies. However, it is important to realise the various strains of probiotics elicit different 
effects and may not have the same effect on everyone.  It is possible that, in general, 
probiotics may be more beneficial for older adults who have less ‘good’ bacteria in their gut 
(Tiwari et al., 2012). 
In terms of both psychological and physiological health maintenance it is recommended for 
individuals to exercise regularly, eat a balanced diet high in fibre and possibly supplement 
with probiotics containing strains of Lactobacilli and Bifidobacteria. 
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